Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2023-05-07 Regulatory Filings
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - MYX 4 pages 23.9KB
Regulatory Filings Classification · 95% confidence The document is a notification about the cessation (lapse) of certain securities (performance rights) of Mayne Pharma Group Limited. It details the number of securities that have ceased, the reason for cessation, and the updated issued capital following these changes. There is no financial data, no report attached or referenced, and the document is an announcement about changes in securities status. This fits the category of Regulatory Filings (RNS) as it is a general regulatory announcement about securities cessation that does not fit into more specific categories like share issue or capital change (SHA) or director dealings (DIRS). The document length is short and it is a straightforward announcement rather than a report or detailed financial disclosure.
2023-05-07 English
Becoming a substantial holder 3 pages 314.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under Corporations Law Section 671B. It details the substantial shareholding of Viburnum Funds Pty Ltd in Mayne Pharma Group Limited, including voting power, relevant interests, registered holders, consideration paid, and associates. This type of filing is a notification of a major shareholding crossing a threshold, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure of shareholding interests.
2023-05-07 English
Notification regarding unquoted securities - MYX 7 pages 29.9KB
Share Issue/Capital Change Classification · 95% confidence The document is a notification regarding the issue of unquoted equity securities under an employee incentive scheme by Mayne Pharma Group Limited. It details the number and type of securities issued, dates, and compliance with ASX listing rules. There is no financial performance data, earnings information, or management discussion. The content focuses on the issuance of securities and related regulatory compliance, which aligns with announcements about share issues or capital changes. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement but a full notification of share issuance.
2023-05-04 English
Notification regarding unquoted securities - MYX 7 pages 30.3KB
Capital/Financing Update Classification · 100% confidence The document is a detailed notification about the issue of unquoted equity securities under an employee incentive scheme by Mayne Pharma Group Limited. It includes specifics such as the number of securities issued, dates, security codes, and references to shareholder approval at the AGM. The content focuses on the issuance of securities, their terms, and compliance with listing rules. There is no financial performance data, earnings information, or management discussion. The document is not a report or presentation but an announcement of a capital issuance event. Therefore, it fits the category of Capital/Financing Update (CAP).
2023-05-04 English
Notification regarding unquoted securities - MYX 6 pages 28.1KB
Share Issue/Capital Change Classification · 100% confidence The document is a notification regarding the issue of unquoted equity securities under an employee incentive scheme by Mayne Pharma Group Limited. It details the number and type of securities issued, dates, and compliance with ASX listing rules. There is no financial performance data, management discussion, or audit information. The content is focused on the issuance of securities, specifically performance rights, and compliance with shareholder approval rules. This fits the category of Share Issue/Capital Change announcements, which cover new share issues and related capital changes.
2023-05-04 English
Change of Director's Interest Notice 2 pages 275.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a change in a director's relevant interests in securities, specifically the acquisition of performance rights by a director. The document includes specifics such as the director's name, date of change, number of securities held before and after the change, and the nature of the change. This matches the definition of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives (insider trades). The document length is 3403 characters, which is consistent with a detailed notice rather than a full report or announcement of a report. Therefore, the correct classification is Director's Dealing (DIRS).
2023-05-04 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.